Compare VTVT & TROO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VTVT | TROO |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 127.0M | 151.5M |
| IPO Year | 2015 | N/A |
| Metric | VTVT | TROO |
|---|---|---|
| Price | $34.63 | $1.67 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $37.00 | N/A |
| AVG Volume (30 Days) | 12.6K | ★ 55.9K |
| Earning Date | 11-06-2025 | 12-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $17,000.00 | ★ $15,084,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 247.24 |
| 52 Week Low | $13.15 | $0.49 |
| 52 Week High | $35.95 | $2.62 |
| Indicator | VTVT | TROO |
|---|---|---|
| Relative Strength Index (RSI) | 70.06 | 70.41 |
| Support Level | $22.92 | $1.21 |
| Resistance Level | $35.95 | $1.75 |
| Average True Range (ATR) | 2.23 | 0.18 |
| MACD | 0.59 | 0.04 |
| Stochastic Oscillator | 89.87 | 86.89 |
vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin, currently in a Phase 3 trial, a potential novel first-in-class oral liver-selective glucokinase activator being investigated for the treatment of type 1 diabetes. The group and its development partners are investigating multiple molecules across different indications for chronic diseases. Its product pipeline are HPP737, Azeliragon, TTP-RA, TTP273, HPP971 / HPP3033, and HPP593.
TROOPS Inc is a conglomerate group of various businesses with its headquarters based in Hong Kong. The group is principally engaged in money lending business in Hong Kong providing mortgage loans to high quality target borrowers, property investment to generate additional rental income and the development, operation and management of an online financial marketplace that provides one-stop financial technology solutions including API services by leveraging artificial intelligence, large data and blockchain, and cloud computing (SaaS). It derives revenue from Hong Kong and Australia. Majority of its revenue generates from domestic market.